iBio Inc. (IBIO)
iBio Statistics
Share Statistics
iBio has 9.87M shares outstanding. The number of shares has increased by 14.51% in one year.
Shares Outstanding | 9.87M |
Shares Change (YoY) | 14.51% |
Shares Change (QoQ) | 7.93% |
Owned by Institutions (%) | 0.08% |
Shares Floating | 8.6M |
Failed to Deliver (FTD) Shares | 9.8K |
FTD / Avg. Volume | 1.92% |
Short Selling Information
The latest short interest is 242K, so 2.64% of the outstanding shares have been sold short.
Short Interest | 242K |
Short % of Shares Out | 2.64% |
Short % of Float | 2.72% |
Short Ratio (days to cover) | 1.91 |
Valuation Ratios
The PE ratio is -0.31 and the forward PE ratio is -1.43. iBio's PEG ratio is 0.
PE Ratio | -0.31 |
Forward PE | -1.43 |
PS Ratio | 34.22 |
Forward PS | 356.4 |
PB Ratio | 0.36 |
P/FCF Ratio | -0.41 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for iBio.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.21.
Current Ratio | 4.08 |
Quick Ratio | 4.08 |
Debt / Equity | 0.21 |
Debt / EBITDA | -0.32 |
Debt / FCF | -0.24 |
Interest Coverage | -96.71 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $14.06K |
Profits Per Employee | $-1.56M |
Employee Count | 16 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 36.01% in the last 52 weeks. The beta is 1.3, so iBio's price volatility has been higher than the market average.
Beta | 1.3 |
52-Week Price Change | 36.01% |
50-Day Moving Average | 4.16 |
200-Day Moving Average | 2.76 |
Relative Strength Index (RSI) | 39.09 |
Average Volume (20 Days) | 510.56K |
Income Statement
In the last 12 months, iBio had revenue of 225K and earned -24.91M in profits. Earnings per share was -6.5.
Revenue | 225K |
Gross Profit | 225K |
Operating Income | -16.63M |
Net Income | -24.91M |
EBITDA | -14.02M |
EBIT | -15.27M |
Earnings Per Share (EPS) | -6.5 |
Balance Sheet
The company has 14.21M in cash and 4.46M in debt, giving a net cash position of 9.75M.
Cash & Cash Equivalents | 14.21M |
Total Debt | 4.46M |
Net Cash | 9.75M |
Retained Earnings | -313.85M |
Total Assets | 21.7M |
Working Capital | 3.58M |
Cash Flow
In the last 12 months, operating cash flow was -18.55M and capital expenditures -210K, giving a free cash flow of -18.76M.
Operating Cash Flow | -18.55M |
Capital Expenditures | -210K |
Free Cash Flow | -18.76M |
FCF Per Share | -4.9 |
Margins
Gross margin is 100%, with operating and profit margins of -7392.89% and -11069.78%.
Gross Margin | 100% |
Operating Margin | -7392.89% |
Pretax Margin | -6863.56% |
Profit Margin | -11069.78% |
EBITDA Margin | -6231.56% |
EBIT Margin | -7392.89% |
FCF Margin | -8339.56% |
Dividends & Yields
IBIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for IBIO is $5, which is 28.5% higher than the current price. The consensus rating is "Buy".
Price Target | $5 |
Price Target Difference | 28.5% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Stock Splits
The last stock split was on Nov 29, 2023. It was a backward split with a ratio of 1:20.
Last Split Date | Nov 29, 2023 |
Split Type | backward |
Split Ratio | 1:20 |
Scores
Altman Z-Score | -19.74 |
Piotroski F-Score | 4 |